<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04340375</url>
  </required_header>
  <id_info>
    <org_study_id>AP-R-2018-01</org_study_id>
    <nct_id>NCT04340375</nct_id>
  </id_info>
  <brief_title>Anti-pollution Effects of AP Green Tea Extracts</brief_title>
  <official_title>A Clinical Study to Evaluate the Anti-pollution Effects of AP Green Tea Extracts in Subjects With Discomforts Related to the Respiratory System by Prolonged Exposure to Particulate Matter in Air Pollution</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amorepacific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amorepacific Corporation</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical trial is to evaluate the anti-pollution effects of AP green&#xD;
      tea extracts in subjects with discomforts related to the respiratory system by prolonged&#xD;
      exposure to particulate matter in air pollution&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 3, 2019</start_date>
  <completion_date type="Actual">April 30, 2020</completion_date>
  <primary_completion_date type="Actual">February 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary function test</measure>
    <time_frame>4 weeks</time_frame>
    <description>Improvement in pulmonary function test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulmonary function test</measure>
    <time_frame>8 weeks</time_frame>
    <description>Improvement in pulmonary function test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory health survey</measure>
    <time_frame>4 weeks</time_frame>
    <description>Patients' self evaluation of COPD Assessment Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory health survey</measure>
    <time_frame>8 weeks</time_frame>
    <description>Patients' self evaluation of COPD Assessment Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomarkers</measure>
    <time_frame>4 weeks</time_frame>
    <description>Blood concentration of biomarkers (Inflammatory cytokines)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomarkers</measure>
    <time_frame>8 weeks</time_frame>
    <description>Blood concentration of biomarkers (Inflammatory cytokines)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heavy metals</measure>
    <time_frame>4 weeks</time_frame>
    <description>Blood concentration of heavy metals</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heavy metals</measure>
    <time_frame>8 weeks</time_frame>
    <description>Blood concentration of heavy metals</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bronchial assessment</measure>
    <time_frame>4 weeks</time_frame>
    <description>Patients' self evaluation of Bronchiectasis Health Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bronchial assessment</measure>
    <time_frame>8 weeks</time_frame>
    <description>Patients' self evaluation of Bronchiectasis Health Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Respiratory Conditions Due to Unspecified External Agent</condition>
  <arm_group>
    <arm_group_label>AP green tea extracts</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>AP green tea extracts</intervention_name>
    <description>AP green tea extracts</description>
    <arm_group_label>AP green tea extracts</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects aged 19 years or over&#xD;
&#xD;
          -  Subjects with discomforts related to the respiratory system by prolonged exposure to&#xD;
             particulate matter in air pollution&#xD;
&#xD;
          -  Subjects who voluntarily decide to participate in this clinical study and sign the&#xD;
             informed consent form on their own or through their representatives&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  At the screening visit, subjects who were diagnosed with acute or chronic respiratory&#xD;
             disease and undergoing medication.&#xD;
&#xD;
          -  Subjects who were diagnosed with ventricular associated disease, unstable and&#xD;
             uncontrolled chronic medical disease, or active malignant tumor and undergoing&#xD;
             medication within 4 weeks prior to the first administration of the investigational&#xD;
             product&#xD;
&#xD;
          -  Subjects who show a level of ALT/AST of 2 times or more the upper limit of normal as a&#xD;
             result of a screening test and have acute or chronic hepatitis or known liver&#xD;
             cirrhosis&#xD;
&#xD;
          -  In addition to the above, subjects who are determined to be ineligible to participate&#xD;
             in the clinical study according to the investigator's medical opinion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hanyang University Seoul Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 31, 2020</study_first_submitted>
  <study_first_submitted_qc>April 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2020</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anti-pollution</keyword>
  <keyword>green tea extracts</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

